Artivion | CRY - Sales Revenues


Artivion reported $115.99M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 12.59B 1.43B Jun/2026
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 153.6M 12.4M Jun/2026
Baxter International USD 2.96B 260M Jun/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Boston Scientific USD 5.44B 240M Jun/2026
Edwards Lifesciences USD 1.74B 90M Jun/2026
Inogen USD 74.93M 504K Sep/2024
Integra LifeSciences USD 418.8M 26.9M Jun/2026
J&J USD 25.31B 1.21B Jun/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 219.91M 14.28M Dec/2025
Pfizer USD 15.03B 530M Jun/2026
ResMed USD 1.46B 60M Jun/2026
Stryker USD 6.6B 600M Jun/2026
Tandem Diabetes Care USD 254.6M 7.38M Jun/2026
Teleflex USD 570.3M 22M Jun/2026
Terumo JPY 311.81B 11.49B Jun/2026
Trinity Biotech USD 11.07M 3.24M Dec/2025